Patents by Inventor Christopher S. Hackett

Christopher S. Hackett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIGEN RECOGNIZING RECEPTORS TARGETING GD3 GANGLIOSIDE AND USES THEREOF
    Publication number: 20240042031
    Abstract: The presently disclosed subject matter provides for antigen-recognizing receptors that specifically target GD3 and cells comprising such GD3-targeted antigen-recognizing receptors. The presently disclosed subject matter further provides uses of the GD3-targeted antigen-recognizing receptors for treatment.
    Type: Application
    Filed: September 28, 2023
    Publication date: February 8, 2024
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Christopher S. Hackett, Renier J. Brentjens, Jedd D. Wolchok, Paul B. Chapman, Sarwish Rafiq, Terence Purdon